Ascendis Pharma A/S (ASND)
214.15
+8.34
(+4.05%)
USD |
NASDAQ |
Jun 09, 15:47
Ascendis Pharma Total Liabilities (Quarterly) : 1.746B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Evaxion AS | 10.43M |
| DBV Technologies SA | 58.50M |
| Genmab A/S | 6.694B |
| Cellectis SA | 229.27M |
| Akari Therapeutics Plc | 19.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.308B |
| Shareholders Equity (Quarterly) | 562.24M |
| Debt to Equity Ratio | 1.838 |
| Current Ratio | 0.9961 |
| Net Debt Paydown Yield | -0.21% |